636 related articles for article (PubMed ID: 15367375)
21. Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices.
Castillo-Garit JA; Marrero-Ponce Y; Torrens F; García-Domenech R
J Pharm Sci; 2008 May; 97(5):1946-76. PubMed ID: 17724669
[TBL] [Abstract][Full Text] [Related]
22. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
23. Exploring the role of different drug transport routes in permeability screening.
Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
[TBL] [Abstract][Full Text] [Related]
24. Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers.
Zheng Y; Yang XW
Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):704-10. PubMed ID: 18601852
[TBL] [Abstract][Full Text] [Related]
25. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
26. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
27. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
[TBL] [Abstract][Full Text] [Related]
28. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth.
Linnankoski J; Ranta VP; Yliperttula M; Urtti A
Eur J Pharm Sci; 2008 Jul; 34(2-3):129-39. PubMed ID: 18455374
[TBL] [Abstract][Full Text] [Related]
29. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
Wang Y; Cao J; Wang X; Zeng S
Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
[TBL] [Abstract][Full Text] [Related]
30. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
31. [Transport mechanism of swertiamain metabolite across Caco-2 model].
Tang C; Zhang Y; Zhang T; Tian C; Liu C
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(17):2258-60. PubMed ID: 19943498
[TBL] [Abstract][Full Text] [Related]
32. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
Bergström CA
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
[TBL] [Abstract][Full Text] [Related]
33. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Baert B; Deconinck E; Van Gele M; Slodicka M; Stoppie P; Bodé S; Slegers G; Vander Heyden Y; Lambert J; Beetens J; De Spiegeleer B
Bioorg Med Chem; 2007 Nov; 15(22):6943-55. PubMed ID: 17827020
[TBL] [Abstract][Full Text] [Related]
34. Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix': application to 'in silico' studies for the rational discovery of new antimalarial compounds.
Marrero-Ponce Y; Montero-Torres A; Zaldivar CR; Veitía MI; Peréz MM; Sánchez RN
Bioorg Med Chem; 2005 Feb; 13(4):1293-304. PubMed ID: 15670938
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
36. QSAR-based permeability model for drug-like compounds.
Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
[TBL] [Abstract][Full Text] [Related]
37. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
Hou T; Wang J; Li Y
J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
[TBL] [Abstract][Full Text] [Related]
38. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.
Palm K; Luthman K; Ros J; Grasjo J; Artursson P
J Pharmacol Exp Ther; 1999 Nov; 291(2):435-43. PubMed ID: 10525056
[TBL] [Abstract][Full Text] [Related]
39. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
40. Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity.
Marrero-Ponce Y; Medina-Marrero R; Torrens F; Martinez Y; Romero-Zaldivar V; Castro EA
Bioorg Med Chem; 2005 Apr; 13(8):2881-99. PubMed ID: 15781398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
